nach oben

Erschienen in:

01.06.2023 | original article

Effect of a protein kinase B (Akt) inhibitor on the angiogenesis of HUVECs and corneal neovascularization

verfasst von: Dr. Xing Wang, M.D., Pro. Peng Wang, M.D.

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2024

Einloggen, um Zugang zu erhalten

Summary Background Methods Results Conclusion

Corneal neovascularization (CNV) is a vision-threatening disease and an increasing public health concern. It was found that administering an Akt inhibitor in the second phase of retinopathy significantly decreased retinal neovascularization.

This study investigated the effect of an Akt inhibitor on the angiogenesis of human umbilical vein endothelial cells (HUVECs) and its impacts on the degree of CNV and corneal opacity in a rat keratoplasty model. Cell Counting Kit-8 (CCK-8) and 5-ethynyl-2′-deoxyuridine (EdU) assays, tube formation assays, cell scratch experiments, and a fully allogeneic corneal transplant model were performed.

It was found that an Akt inhibitor inhibited the proliferation, angiogenesis, and migration of HUVECs induced by vascular endothelial growth factor (VEGF). The results showed that both CNV and corneal opacity were decreased in rats after Akt inhibitor administration.

The research illustrates the vital role of Akt inhibitors in mediating CNV. The analysis shows that the Akt inhibitor may provide a novel and feasible therapeutic approach to prevent CNV, but its mechanism needs further investigation.

Vorheriger Artikel Peculiarities of melatonin levels in preterm infants

Nächster Artikel Downregulation of lncRNA LINC01465 predicts ovarian endometriosis and its prognosis

Beebe DC. Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol. 2008; https://doi.org/10.1016/j.semcdb.2007.08.014.CrossRefPubMed

Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245–69. https://doi.org/10.1016/s0039-6257(98)00035-6.CrossRefPubMed

Abdelfattah NS, Amgad M, Zayed AA, et al. Clinical correlates of common corneal neovascular diseases: a literature review. Int J Ophthalmol. 2015;8:182–93. https://doi.org/10.3980/j.issn.2222-3959.2015.01.32.CrossRefPubMedPubMedCentral

Cherry PM, Faulkner JD, Shaver RP, et al. Argon laser treatment of corneal neovascularization. Ann Ophthalmol. 1973;5:911–20.PubMed

Reed JW, Fromer C, Klintworth GK. Induced corneal vascularization remission with argon laser therapy. Arch Ophthalmol. 1975;93:1017–9. https://doi.org/10.1001/archopht.1975.01010020797012.CrossRefPubMed

Gomer CJ, Ferrario A, Hayashi N, et al. Molecular, cellular, and tissue responses following photodynamic therapy. Lasers Surg Med. 1988;8:450–63. https://doi.org/10.1002/lsm.1900080503.CrossRefPubMed

Gore A, Horwitz V, Cohen M, et al. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model. Exp Eye Res. 2018;171:183–91. https://doi.org/10.1016/j.exer.2018.03.010.CrossRefPubMed

Peterson JS, Chen W, Libin BM, et al. Sustained ocular delivery of bevacizumab using densomeres in rabbits: effects on molecular integrity and bioactivity. Transl Vis Sci Technol. 2023;12:28. https://doi.org/10.1167/tvst.12.3.28.CrossRefPubMedPubMedCentral

Al-Debasi T, Al-Bekairy A, Al-Katheri A, et al. Topical versus subconjunctival anti-vascular endothelial growth factor therapy (bevacizumab, ranibizumab and aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol. 2017;31:99–105. https://doi.org/10.1016/j.sjopt.2017.02.008.CrossRefPubMedPubMedCentral

10.

Celenk M, Yildirim H, Tektemur A, et al. Effect of topical motesanib in experimental corneal neovascularization model. Int Ophthalmol. 2023; https://doi.org/10.1007/s10792-023-02685-3.CrossRefPubMed

11.

Gomes Souza L, Antonio Sousa-Junior A, Alves Santana Cintra B, et al. Pre-clinical safety of topically administered sunitinib-loaded lipid and polymeric nanocarriers targeting corneal neovascularization. Int J Pharm. 2023;635:122682. https://doi.org/10.1016/j.ijpharm.2023.122682.CrossRefPubMed

12.

Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3‑kinase. Cell. 1995;81:727–36. https://doi.org/10.1016/0092-8674(95)90534-0.CrossRefPubMed

13.

Hemmings BA. PH domains—a universal membrane adapter. Science. 1997;275:1899. https://doi.org/10.1126/science.275.5308.1899.CrossRefPubMed

14.

Hemmings BA. PtdIns(3,4,5)P3 gets its message across. Science. 1997;277:534. https://doi.org/10.1126/science.277.5325.534.CrossRefPubMed

15.

Chen J, Li F, Xu Y, et al. Cholesterol modification of SDF-1-specific siRNA enables therapeutic targeting of angiogenesis through Akt pathway inhibition. Exp Eye Res. 2019;184:64–71. https://doi.org/10.1016/j.exer.2019.03.006.CrossRefPubMedADS

16.

Luo Z, Fujio Y, Kureishi Y, et al. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest. 2000;106:493–9. https://doi.org/10.1172/JCI9419.CrossRefPubMedPubMedCentral

17.

Papapetropoulos A, Garcia-Cardena G, Madri JA, et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997;100:3131–9. https://doi.org/10.1172/JCI119868.CrossRefPubMedPubMedCentral

18.

Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567–78. https://doi.org/10.1172/JCI1560.CrossRefPubMedPubMedCentral

19.

Berger I, Stahl S, Rychkova N, et al. VEGF receptors on PC12 cells mediate transient activation of ERK1/2 and Akt: comparison of nerve growth factor and vascular endothelial growth factor. J Negat Results BioMed. 2006;5:8. https://doi.org/10.1186/1477-5751-5-8.CrossRefPubMedPubMedCentral

20.

Wang P, Tian XF, Rong JB, et al. Protein kinase B (akt) promotes pathological angiogenesis in murine model of oxygen-induced retinopathy. Acta Histochem Cytochem. 2011;44:103–11. https://doi.org/10.1267/ahc.10038.CrossRefPubMedPubMedCentral

21.

Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem. 1998;273:30336–43. https://doi.org/10.1074/jbc.273.46.30336.CrossRefPubMed

22.

Fujio Y, Guo K, Mano T, et al. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol. 1999;19:5073–82. https://doi.org/10.1128/MCB.19.7.5073.CrossRefPubMedPubMedCentral

23.

Fujio Y, Nguyen T, Wencker D, et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101:660–7. https://doi.org/10.1161/01.cir.101.6.660.CrossRefPubMedPubMedCentral

24.

Zhan M, Han ZC. Phosphatidylinositide 3‑kinase/AKT in radiation responses. Histol Histopathol. 2004;19:915–23. https://doi.org/10.14670/HH-19.915.CrossRefPubMed

25.

Chen J, Somanath PR, Razorenova O, et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med. 2005;11:1188–96. https://doi.org/10.1038/nm1307.CrossRefPubMedPubMedCentral

26.

Nishiyama K, Takaji K, Kataoka K, et al. Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesis. Circulation. 2005;112:2840–50. https://doi.org/10.1161/CIRCULATIONAHA.104.516898.CrossRefPubMed

27.

Wang X, Ye H, Yang S, et al. Disulfiram exerts antifibrotic and anti-inflammatory therapeutic effects on perimysial orbital fibroblasts in graves’ orbitopathy. Int J Mol Sci. 2022; https://doi.org/10.3390/ijms23095261.CrossRefPubMedPubMedCentral

28.

Yang J, Feng S, Yi G, et al. Inhibition of RelA expression via RNA interference induces immune tolerance in a rat keratoplasty model. Mol Immunol. 2016;73:88–97. https://doi.org/10.1016/j.molimm.2016.03.014.CrossRefPubMed

29.

Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice—evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694–704. https://doi.org/10.1097/00007890-199210000-00026.CrossRefPubMed

30.

Seo M, Choi JS, Rho CR, et al. MicroRNA miR-466 inhibits lymphangiogenesis by targeting prospero-related homeobox 1 in the alkali burn corneal injury model. J Biomed Sci. 2015;22:3. https://doi.org/10.1186/s12929-014-0104-0.CrossRefPubMedPubMedCentral

31.

Nosov M, Wilk M, Morcos M, et al. Role of lentivirus-mediated overexpression of programmed death-ligand 1 on corneal allograft survival. Am J Transplant. 2012;12:1313–22. https://doi.org/10.1111/j.1600-6143.2011.03948.x.CrossRefPubMed

32.

Niederkorn JY. Immunology and immunomodulation of corneal transplantation. Int Rev Immunol. 2002;21:173–96. https://doi.org/10.1080/08830180212064.CrossRefPubMed

33.

Fan X, Qiu J, Yuan T, et al. Piperlongumine alleviates corneal allograft rejection via suppressing angiogenesis and inflammation. Front Immunol. 2022;13:1090877. https://doi.org/10.3389/fimmu.2022.1090877.CrossRefPubMedPubMedCentral

34.

Shakiba Y, Mansouri K, Arshadi D, et al. Corneal neovascularization: molecular events and therapeutic options. Recent Pat Inflamm Allergy Drug Discov. 2009;3:221–31. https://doi.org/10.2174/187221309789257450.CrossRefPubMed

35.

Liu G, Lu P, Li L, et al. Critical role of SDF-1alpha-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. Mol Vis. 2011;17:2129–38.PubMedPubMedCentralADS

36.

Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci. 1994;35:3649–63.PubMed

37.

Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor‑1. Nature. 2006;443:993–7. https://doi.org/10.1038/nature05249.CrossRefPubMedPubMedCentralADS

38.

Xiao O, Xie ZL, Lin BW, et al. Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS ONE. 2012;7:e41858. https://doi.org/10.1371/journal.pone.0041858.CrossRefPubMedPubMedCentralADS

39.

Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002;90:1243–50. https://doi.org/10.1161/01.res.0000022200.71892.9f.CrossRefPubMed

40.

Park JK, Peng H, Yang W, et al. miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways. FASEB J. 2017;31:256–65. https://doi.org/10.1096/fj.201600746R.CrossRefPubMed

41.

Huang X, Ni B, Mao Z, et al. NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway. J Cell Mol Med. 2019;23:7525–34. https://doi.org/10.1111/jcmm.14621.CrossRefPubMedPubMedCentral

42.

Pegoretti V, Baron W, Laman JD, et al. Selective modulation of TNF-TNFRs signaling: insights for multiple sclerosis treatment. Front Immunol. 2018;9:925. https://doi.org/10.3389/fimmu.2018.00925.CrossRefPubMedPubMedCentral

43.

Hamidi A, Song J, Thakur N, et al. TGF-beta promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85alpha. Sci Signal. 2017; https://doi.org/10.1126/scisignal.aal4186.CrossRefPubMed

44.

Gross SM, Rotwein P. Mapping growth-factor-modulated Akt signaling dynamics. J Cell Sci. 2016;129:2052–63. https://doi.org/10.1242/jcs.183764.CrossRefPubMedPubMedCentral

45.

Qian J, Yu J, Zhu X, et al. MiR-335 promotes corneal neovascularization by targeting EGFR. BMC Ophthalmol. 2022;22:267. https://doi.org/10.1186/s12886-022-02481-0.CrossRefPubMedPubMedCentral

46.

Huo YN, Yeh SD, Lee WS. Androgen receptor activation reduces the endothelial cell proliferation through activating the cSrc/AKT/p38/ERK/NFkappaB-mediated pathway. J Steroid Biochem Mol Biol. 2019;194:105459. https://doi.org/10.1016/j.jsbmb.2019.105459.CrossRefPubMed

47.

Park JY, Ji YS, Zhu H, et al. Anti-angiogenic effect of asperchalasine a via attenuation of VEGF signaling. Biomolecules. 2019; https://doi.org/10.3390/biom9080358.CrossRefPubMedPubMedCentral

48.

Wu Y, Wang Y, Nabi X. Protective effect of ziziphora clinopodioides flavonoids against H2O2-induced oxidative stress in HUVEC cells. Biomed Pharmacother. 2019;117:109156. https://doi.org/10.1016/j.biopha.2019.109156.CrossRefPubMed

49.

Cao Q, Lu W, Zhou T, et al. Analgesic-antitumor peptide inhibits angiogenesis by suppressing AKT activation in hepatocellular carcinoma. Mol Cell Biochem. 2019;455:119–25. https://doi.org/10.1007/s11010-018-3475-9.CrossRefPubMed

50.

Zhao Z, Zhang Y, Zhang C, et al. TGF-beta promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways. Exp Mol Med. 2022;54:673–84. https://doi.org/10.1038/s12276-022-00778-0.CrossRefPubMedPubMedCentral

51.

Yang Y, Jin H, Qiu Y, et al. Reactive oxygen species are essential for placental angiogenesis during early gestation. Oxid Med Cell Longev. 2022;2022:4290922. https://doi.org/10.1155/2022/4290922.CrossRefPubMedPubMedCentral

52.

Lee II, Maniar K, Lydon JP, et al. Akt regulates progesterone receptor B‑dependent transcription and angiogenesis in endometrial cancer cells. Oncogene. 2016;35:5191–201. https://doi.org/10.1038/onc.2016.56.CrossRefPubMedPubMedCentral

53.

Chen J, Chen P, Backman LJ, et al. Ciliary neurotrophic factor promotes the migration of corneal epithelial stem/progenitor cells by up-regulation of MMPs through the phosphorylation of Akt. Sci Rep. 2016;6:25870. https://doi.org/10.1038/srep25870.CrossRefPubMedPubMedCentralADS

54.

Liu Y, Di G, Wang Y, et al. Aquaporin 5 facilitates corneal epithelial wound healing and nerve regeneration by reactivating Akt signaling pathway. Am J Pathol. 2021;191:1974–85. https://doi.org/10.1016/j.ajpath.2021.07.010.CrossRefPubMed

Titel: Effect of a protein kinase B (Akt) inhibitor on the angiogenesis of HUVECs and corneal neovascularization
verfasst von: Dr. Xing Wang, M.D.
Pro. Peng Wang, M.D.
Publikationsdatum: 01.06.2023
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 5-6/2024
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-023-02208-1

MUW researcher of the month

MUW researcher of the month

Ethics teaching in medical school: the perception of medical students

Open Access
Medizinethik
Redaktionstipp

Peculiarities of melatonin levels in preterm infants

original article

Downregulation of lncRNA LINC01465 predicts ovarian endometriosis and its prognosis

original article

Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis

original article

Non-genetic physicians’ knowledge, attitudes and behavior towards medical genetics

original article

Springer Medizin Österreich

Effect of a protein kinase B (Akt) inhibitor on the angiogenesis of HUVECs and corneal neovascularization

Summary Background Methods Results Conclusion

Weitere Artikel der Ausgabe 5-6/2024

MUW researcher of the month

Ethics teaching in medical school: the perception of medical students

Peculiarities of melatonin levels in preterm infants

Downregulation of lncRNA LINC01465 predicts ovarian endometriosis and its prognosis

Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis

Non-genetic physicians’ knowledge, attitudes and behavior towards medical genetics

Springer Medizin Österreich

Summary Background Methods Results Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

MUW researcher of the month

Ethics teaching in medical school: the perception of medical students

Peculiarities of melatonin levels in preterm infants

Downregulation of lncRNA LINC01465 predicts ovarian endometriosis and its prognosis

Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis

Non-genetic physicians’ knowledge, attitudes and behavior towards medical genetics